Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2001
03/22/2001CA2384766A1 Subunit optimized fusion proteins
03/22/2001CA2384762A1 Apo-2 receptor antibodies
03/22/2001CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same
03/22/2001CA2384660A1 Factor ix/factor ixa antibodies and antibody derivatives
03/22/2001CA2384324A1 Proteins associated with cell differentiation
03/22/2001CA2384294A1 Nicotinic acetylcholine receptor: alpha10 subunit
03/22/2001CA2384135A1 Dipeptidyl peptidases
03/22/2001CA2383927A1 Protein phosphatase and kinase proteins
03/22/2001CA2383423A1 Reverse transfection method
03/22/2001CA2383360A1 Pharmaceutical compositions and methods of using secreted frizzled related protein
03/22/2001CA2383217A1 Lysosomal targeting pathway enzymes
03/22/2001CA2383177A1 Human g-protein coupled receptor
03/22/2001CA2382444A1 Dna construct and its use
03/22/2001CA2382067A1 Recombinant microorganisms
03/22/2001CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
03/22/2001CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
03/22/2001CA2350823A1 Thermostable luciferases from photuris pennsylvanica and pyrophorus plagiophthalamus and methods of production
03/21/2001EP1085093A2 Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof
03/21/2001EP1085092A1 Phosphodiesterase enzymes
03/21/2001EP1085089A2 Human cyclic nucleotide phosphodiesterase
03/21/2001EP1085088A1 Monoclonal antibodies and method for assaying fdp
03/21/2001EP1085085A1 Process for reducing specific immune reactions
03/21/2001EP1085084A1 Chondrocytes compositions, preparation and use
03/21/2001EP1085083A1 Media for culturing animal cells and process for producing protein by using the same
03/21/2001EP1085082A1 Methods and compositions for chondrocytes preservation and uses therefor
03/21/2001EP1085024A1 Peptides having nuclear transport activity
03/21/2001EP1084278A1 Detection of dna, rna and proteins
03/21/2001EP1084274A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein)
03/21/2001EP1084267A1 Vitamin c production in microorganisms and plants
03/21/2001EP1084263A1 Hematopoietic progenitor cell gene transduction
03/21/2001EP1084260A2 Caspase-9 deficient animals and the use thereof
03/21/2001EP1084259A1 Corin, a serine protease
03/21/2001EP1084256A2 Acyl coa:cholesterol acyltransferase related nucleic acid sequences
03/21/2001EP1084252A1 Nucleic acid vaccines for prevention of flavivirus infection
03/21/2001EP1084250A2 Enzyme
03/21/2001EP1084249A2 Transgenic plant cells expressing a recombinant plant e2f peptide
03/21/2001EP1084248A2 Novel insulin analogs with enhanced zinc binding
03/21/2001EP1084246A2 Biological material for preparing pharmaceutical compositions for treating mammals
03/21/2001EP1084242A2 Phagocytic assay method
03/21/2001EP1084241A1 G-protein coupled receptor, named 2871 receptor
03/21/2001EP1084239A1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1)
03/21/2001EP1084236A1 Novel adenoviral vectors for gene therapy
03/21/2001EP1084235A1 Human protein c polypeptide
03/21/2001EP1084233A1 Packaging kit
03/21/2001EP1084232A1 Genetically-modified fibroblasts and the use thereof
03/21/2001EP1084231A1 Transformed cell lines which express heterologous g-protein-coupled receptors
03/21/2001EP1084230A2 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
03/21/2001EP1084229A1 The production of primmorphs from disassociated cells of sponges, corals and other invertebrates, and use thereof
03/21/2001EP1084228A1 GENES CODING FOR TOMATO beta-GALACTOSIDASE POLYPEPTIDES
03/21/2001EP1084227A1 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
03/21/2001EP1084142A1 Gpr35a receptor
03/21/2001EP1084141A1 nrdF
03/21/2001EP1084135A1 The human kidney specific gene kk86
03/21/2001EP1083984A1 Method for populating substrates with biological cells and populating devices that can be used therefor
03/21/2001EP1083945A1 Encapsulation devices with strand, yarn or mesh core
03/21/2001EP1083934A2 Gene therapy method
03/21/2001EP1083927A1 HUMAN MINOR VAULT PROTEIN p193
03/21/2001EP1083923A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein)
03/21/2001EP1083910A1 nrdE
03/21/2001EP1083909A1 hCEPR RECEPTOR
03/21/2001EP0797678B1 Hybrid adenovirus-aav virus and method of use thereof
03/21/2001EP0539518B1 Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction
03/21/2001CN1288469A Monoclonal antibody anti alpha; V-integrin and it use to inhibit & alpha; V & beta; 6-integrain attachment to fibronectine
03/21/2001CN1288468A Antibodies against human IL-12
03/21/2001CN1288388A Stabilization of lipid DNA formulations during nebulization
03/21/2001CN1288382A Sea cucumber carotenoid lipid fraction products and method of use
03/21/2001CN1063488C DNA amplification
03/20/2001US6204437 Nucleotide sequences coding regulatory sequences for the control of gene expression in tomato
03/20/2001US6204435 Nucleotide sequences which code insect poison; for biological pest control
03/20/2001US6204432 PA28 modified transgenic mice
03/20/2001US6204371 Compositions and methods for the treatment and diagnosis of immune disorders
03/20/2001US6204367 Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum
03/20/2001US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same
03/20/2001US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells.
03/20/2001US6204060 Viral vectors and line for gene therapy
03/20/2001US6204057 Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles
03/20/2001US6204056 Micropathological patient replica based on unadulterated whole blood
03/20/2001US6204054 Transcytosis vehicles and enchancers for drug delivery
03/20/2001US6204053 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
03/20/2001US6204047 Growth differentiation factor-10
03/20/2001US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease
03/20/2001US6204042 Isolated polynucleotide segment
03/20/2001US6204022 Low-toxicity human interferon-alpha analogs
03/20/2001US6204011 Human receptor tyrosine kinase, KDR
03/20/2001US6204001 Methods for determining compounds capable of inhibiting the activities of the Ha-Ras oncongene
03/20/2001US6203998 Human dopamine receptor and its uses
03/20/2001US6203986 Visualization of RNA in living cells
03/20/2001US6203979 Polynucleotide which codes for protein of defined amino acid sequences; diagnosis, prevention, and therapy of cell proliferative and immune disorders; anticarcinogenic agents; antiproliferative/antiarthritic agents; crohn's disease
03/20/2001US6203793 Compositions and methods for treating thermal injury
03/20/2001US6203789 Treating erythrocytes with s-nitroso-cysteine, homocysteine, or cysteinylglycine to reduce blood pressure
03/20/2001US6203787 Treating tumors using implants comprising combinations of allogeneic cells
03/20/2001CA2318519A1 Genes and polypeptides associated with ultraviolet radiation-mediated skin damage and uses thereof
03/20/2001CA2022959C Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin
03/15/2001WO2001018547A1 Essential genes and assays relating thereto
03/15/2001WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells
03/15/2001WO2001018232A2 Drug target isogenes: polymorphisms in the uncoupling protein 3 (mitochondrial, proton carrier) gene
03/15/2001WO2001018216A2 26176, a novel calpain protease and uses thereof
03/15/2001WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
03/15/2001WO2001018203A1 Opg fusion protein compositions and methods
03/15/2001WO2001018198A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia